R87.619 ICD 10 Code is a billable and specific code that can be used to indicate a diagnosis of Unspecified abnormal cytological findings in specimens from cervix uteri for reimbursement purposes. The 2023 edition of the American ICD-10-CM code became effective on October 1, 2022.
Short description for R87.619 ICD 10 code:
Unsp abnormal cytolog findings in specmn from cervix uteri
Terms applicables to R87.619 ICD 10 code
Possible back-references that may be applicable or related to R87.619 ICD10 Code:
- R00-R99 Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- R83-R89 Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis
- R87 Abnormal findings in specimens from female genital organs
- R87.6 Abnormal cytological findings in specimens from female genital organs
- R87.61 Abnormal cytological findings in specimens from cervix uteri
- R87.62 Abnormal cytological findings in specimens from vagina
- R87.8 Other abnormal findings in specimens from female genital organs
- R87.81 High risk human papillomavirus (HPV) DNA test positive from female genital organs
- R87.82 Low risk human papillomavirus (HPV) DNA test positive from female genital organs
Present On Admission (POA Exempt)
R87.619 ICD 10 code is considered exempt from POA reporting
Clinical information about R87.619 ICD 10 code
The cervix is the lower part of the uterus, the place where a baby grows during pregnancy. Cancer screening is looking for cancer before you have any symptoms. Cancer found early may be easier to treat.
Cervical cancer screening is usually part of a woman's health checkup. There are two types of tests: the Pap test and the HPV test. For both, the doctor or nurse collects cells from the surface of the cervix. With the Pap test, the lab checks the sample for cancer cells or abnormal cells that could become cancer later. With the HPV test, the lab checks for HPV infection. HPV is a virus that spreads through sexual contact. It can sometimes lead to cancer. If your screening tests are abnormal, your doctor may do more tests, such as a biopsy.
Cervical cancer screening has risks. The results can sometimes be wrong, and you may have unnecessary follow-up tests. There are also benefits. Screening has been shown to decrease the number of deaths from cervical cancer. You and your doctor should discuss your risk for cervical cancer, the pros and cons of the screening tests, at what age to start being screened, and how often to be screened.
The information in this box was provided by MedlinePlus.gov